HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Proposes Introduction of Administrative Fines for Improperly Earned Revenues
November 27, 2018
-
BUSINESS Dissident Takeda Shareholders Making Final Pitch to Thwart Shire Buyout
November 26, 2018
-
REGULATORY MHLW Eyes Drastic Change to Cost Effective Analysis Flow, Enhanced Discussions Upfront
November 22, 2018
-
REGULATORY MHLW Proposes Quarterly Product Selections, Price Tweaks for CEA Scheme: Chuikyo
November 22, 2018
-
BUSINESS Pfizer’s ALK Inhibitor Lorbrena, Shire’s HAE Drug Now Available in Japan
November 21, 2018
-
BUSINESS Mitsubishi Tanabe Cuts FY2020 Targets in 5-Year Biz Plan on Flagging Royalty, Development Delay
November 21, 2018
-
BUSINESS 3 Japan Generic Majors Log 6% Growth in Combined April-September Sales despite Price Revision
November 20, 2018
-
BUSINESS 4 Major Wholesalers See 46.1% Increase in 1st Half Operating Profit due to Reductions in Yakkasa and SGA Costs
November 19, 2018
-
BUSINESS AstraZeneca Japan Set to Roll Out 4 New Treatments Every Year through 2021: Chief
November 16, 2018
-
REGULATORY Keytruda’s MSI-H Cancer Use Up for MHLW Panel Review Nov. 29; Wider Hemlibra Indication, 1st Line Tecentriq Also on Agenda
November 16, 2018
-
BUSINESS Hib Vaccine Wind-Up, Development Flop Trigger GSK, Daiichi Sankyo to Shutter JV
November 15, 2018
-
REGULATORY Chuikyo Agrees on October 2019 Drug Price Revision for Tax Hike, but Final Call Is Up to Govt
November 15, 2018
-
REGULATORY Maviret Faces 25% Price Slash in Quarterly Review
November 14, 2018
-
BUSINESS GSK, Daiichi Sankyo Dissolve Vaccine JV
November 14, 2018
-
REGULATORY Novartis’ SMA Gene Therapy Filed in Japan on Nov. 1 after US, EU; What Will Happen to Sakigake Status?
November 13, 2018
-
BUSINESS Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
November 13, 2018
-
BUSINESS Takeda: De-facto Vote on Shire Deal Set for Dec. 5
November 12, 2018
-
BUSINESS Japan Is Top Strategic Market for Biogen: CEO
November 12, 2018
-
ORGANIZATION 7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey
November 9, 2018
-
REGULATORY LDP Health Bigwigs Agree to Push for October 2019 Revision
November 9, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
